3Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101(6):1644-1655.
4Conejero R,Bonet A,Grau T,et al.Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome:a randomized,single-blind,prospective,multicenter study[J].Nutrition,2002,18(9):716-721.
5Angstwurm MW,Schottdorf J,Schopohl J,et al.Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome[J].Crit Care Med,1999,27(9):1807-1813.
6López Martínez J,Sánchez Castilla M,de Juana Velasco P,et al.Non-glucose carbohydrates in the parenteral nutrition of patients with systemic inflammatory response syndrome[J].Nutr Hosp,1999,14(2):71-80.
7Bastian L,Weimann A,Regel G,et al.Is modification of systemic inflammatory response syndrome and multiple organ failure by parenteral feeding possible[J].Langenbecks Arch Chir Suppl Kongressbd,1998(115):1083-1085.
8Bower RH,Cerra FB,Bershadsky B,et al.Early enteral administration of a formula (Impact) supplemented with arginine,nucleotides,and fish oil in intensive care unit patients:results of a multicenter,prospective,randomized,clinical trial[J].Crit Care Med,1995,23(3):436-449.
9Cerra FB,McPherson JP,Konstantinides FN,et al.Ente-ral nutrition does not prevent multiple organ failure syndrome (MOFS) after sepsis[J].Surgery,1988,104(4):727-733.
10Weimann A,Bastian L,Bischoff WE,et al.Influence of arginine,omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma[J].Nutrition,1998,14(2):165-172.
